Min Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Min Zhang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Hui Xie
College of Integrated Traditional Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, China
1 shared publicationLing Zhang
College of Integrated Traditional Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, China
1 shared publicationMei‐Ju Yang
Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, China
1 shared publication- Miao Yan
Department of Pharmacy, The Second Xiangya Hospital of Central South University, China
1 shared publication - Xinrong Fan
Experimental Research Center, China Academy of Chinese Medical Sciences Beijing China
1 shared publication - Xizhong Shen
Yellow River Institute of Hydraulic Research, Yellow River Conservancy Commission, Zhengzhou 450003, China
1 shared publication
Latest Publications
- 1 January 2023
- Published by Curran Associates, Inc.
- p. 1014-1020
Safety Assessment of the Yellow River Control Revetment of Flat Stones in Zhoumenqian of Liaocheng
- 1 January 2023
- Published by Curran Associates, Inc.
- p. 1014-1020
Safety Assessment of the Yellow River Control Revetment of Flat Stones in Zhoumenqian of Liaocheng
- 15 February 2019
- Published by Wiley in Phytotherapy Research
- Vol. 33 (4) , 1191-1198
Celastrol attenuates renal injury in diabetic rats via MAPK/NF‐κB pathway
The purpose of this study was to investigate the renal protective effect of celastrol on diabetic rats. Furthermore, the mechanism of its action was discussed whether it was related to MAPK/NF‐κB signaling pathway. There were a total of 36 rats. Six rats were randomly chosen as the control group. The remaining 30 rats were given 1% streptozotocin intraperitoneal injection (50 mg/kg) and were randomly divided into five groups: the model control group, the low‐dose celastrol group, the high‐dose celastrol group, the Tripterygium wilfordii polyglycosides group, and the MAPK/NF‐κB inhibitor group. After 4 weeks of continuous administration, 24‐hr urine volume, urinary protein, blood urea nitrogen, and serum creatinine content were observed, and hematoxylin–eosin (HE) staining of the kidney and liver were evaluated. p38MAPK was designated by immunohistochemical method, and NF‐κB p65 in renal tissue was detected by western blotting. Our results showed that celastrol could not only reduce contents of creatinine and urea nitrogen in blood but also reduce excretion of urinary protein in diabetic rats, improve renal pathological injury, and down‐regulate the expression of p38MAPK and NF‐κB p65. In conclusion, celastrol could protect kidney of diabetic rats by regulating the signal pathway of MAPK/NF‐κB, inhibiting inflammation and delaying renal injury.
- 15 February 2019
- Published by Wiley in Phytotherapy Research
- Vol. 33 (4) , 1191-1198
Celastrol attenuates renal injury in diabetic rats via MAPK/NF‐κB pathway
The purpose of this study was to investigate the renal protective effect of celastrol on diabetic rats. Furthermore, the mechanism of its action was discussed whether it was related to MAPK/NF‐κB signaling pathway. There were a total of 36 rats. Six rats were randomly chosen as the control group. The remaining 30 rats were given 1% streptozotocin intraperitoneal injection (50 mg/kg) and were randomly divided into five groups: the model control group, the low‐dose celastrol group, the high‐dose celastrol group, the Tripterygium wilfordii polyglycosides group, and the MAPK/NF‐κB inhibitor group. After 4 weeks of continuous administration, 24‐hr urine volume, urinary protein, blood urea nitrogen, and serum creatinine content were observed, and hematoxylin–eosin (HE) staining of the kidney and liver were evaluated. p38MAPK was designated by immunohistochemical method, and NF‐κB p65 in renal tissue was detected by western blotting. Our results showed that celastrol could not only reduce contents of creatinine and urea nitrogen in blood but also reduce excretion of urinary protein in diabetic rats, improve renal pathological injury, and down‐regulate the expression of p38MAPK and NF‐κB p65. In conclusion, celastrol could protect kidney of diabetic rats by regulating the signal pathway of MAPK/NF‐κB, inhibiting inflammation and delaying renal injury.